T1	Procedure 81 104	total knee arthroplasty
T2	Procedure-Name 81 104	total knee arthroplasty
E1	Procedure:T1 Name:T2
T3	Condition 201 221	rheumatoid arthritis
T4	Condition-Name 201 221	rheumatoid arthritis
E3	Condition:T3 Name:T4
T5	Condition 149 163	osteoarthritis
T6	Condition-Name 149 163	osteoarthritis
E5	Condition:T5 Name:T6
T7	Life-Stage-And-Gender 25 30	Adult
A1	Life-Stage-And-Gender-Type T7 adult
T10	Condition 606 628	deep venous thrombosis
T11	Condition-Name 606 628	deep venous thrombosis
E10	Condition:T10 Name:T11
T12	Procedure 1050 1071	anticoagulant therapy
T13	Procedure-Name 1050 1071	anticoagulant therapy
E12	Procedure:T12 Name:T13 Temporality:E63
T14	Condition 776 795	atrial fibrillation
T15	Condition-Name 776 795	atrial fibrillation
E14	Condition:T14 Name:T15
T16	Condition 653 669	renal impairment
T17	Condition-Name 653 669	renal impairment
E16	Condition:T16 Name:T17
T18	Condition 1105 1127	fibrinolytic disorders
T19	Condition-Name 1105 1127	fibrinolytic disorders
E18	Condition:T18 Name:T19
T20	Condition 1181 1193	coagulopathy
T21	Condition-Name 1181 1193	coagulopathy
E20	Condition:T20 Name:T21
T22	Life-Stage-And-Gender 966 973	females
A2	Life-Stage-And-Gender-Type T22 female
T23	Condition 924 930	anemia
T24	Condition-Name 924 930	anemia
E23	Condition:T23 Name:T24
T26	Eq-Operator 954 955	<
A4	Eq-Operator-Value T26 LT
T28	Eq-Operator 1072 1078	within
A6	Eq-Operator-Value T28 LTEQ
T31	Eq-Operator 1296 1297	>
A9	Eq-Operator-Value T31 GT
T32	Eq-Temporal-Unit 1084 1088	days
A10	Eq-Temporal-Unit-Value T32 day
T33	Eq-Unit 1254 1257	mm3
T34	Eq-Value 955 957	11
T35	Eq-Value 979 981	12
T36	Eq-Value 1246 1253	150,000
T39	Eq-Comparison 954 962	<11 g/dL
E24	Eq-Comparison:T39 Operator:T26 Value:T34 Unit:T109 Unit2:T110
T40	Eq-Comparison 978 986	<12 g/dL
E25	Eq-Comparison:T40 Value:T35 Unit:T111 Unit2:T112
T41	Eq-Comparison 1245 1257	<150,000/mm3
E26	Eq-Comparison:T41 Value:T36 Operator:T134 Per:T33
T43	Eq-Comparison 1296 1300	>1.4
E28	Eq-Comparison:T43 Operator:T31
T25	Assertion 44 51	plan to
E2	Assertion:T25 Asserted:E1
A3	Assertion-Type-Value E2 intention
T27	Modifier 60 80	simultaneous primary
E4	Modifier:T27 Modifies:T2
T29	Modifier 108 128	bilateral knee joint
E6	Modifier:T29 Modifies:T2
T30	And 129 133	with
E7	And:T30 Arg:E1 Arg2:E5
T37	Condition 167 188	aseptic bone necrosis
E9	Condition:T37 Name:T38
T38	Condition-Name 167 188	aseptic bone necrosis
T42	Or 164 166	or
E11	Or:T42 Arg:E5 Arg2:E9
T44	Negation 194 197	not
E13	Negation:T44 Negates:E3
T45	And 190 193	but
E15	And:T45 Arg:E9 Arg2:E13
T46	Procedure 260 269	operative
E17	Procedure:T46 Name:T47
T47	Procedure-Name 260 269	operative
T48	Observation 270 284	platelet count
E19	Observation:T48 Name:T49 Polarity:T51
T49	Observation-Name 270 284	platelet count
A5	Observation-Type-Value T49 lab
T50	Temporal-Connection 257 260	pre
E21	Temporal-Connection:T50 Arg:E19 Arg2:E17
A7	Temporal-Connection-Type-Value E21 before
T51	Polarity 250 256	normal
A8	Polarity-Value T51 normal
T52	Observation 293 309	prothrombin time
E22	Observation:T52 Name:T53 Polarity:T54
T53	Observation-Name 293 309	prothrombin time
A11	Observation-Type-Value T53 lab
T54	Polarity 286 292	normal
A12	Polarity-Value T54 normal
T55	Observation 318 345	partial thromboplastin time
E27	Observation:T55 Name:T56 Polarity:T57
T56	Observation-Name 318 345	partial thromboplastin time
A13	Observation-Type-Value T56 lab
T57	Polarity 311 317	normal
A14	Polarity-Value T57 normal
T58	Observation 358 388	international normalized ratio
E29	Observation:T58 Name:T59 Polarity:T60
T59	Observation-Name 358 388	international normalized ratio
A15	Observation-Type-Value T59 lab
T60	Polarity 351 357	normal
A16	Polarity-Value T60 normal
T61	And 347 350	and
E30	And:T61 Arg:E27 Arg2:E29
T62	And 40 43	who
E31	And:T62 Arg:T7 Arg2:E2
T63	Procedure 461 486	plasma volume restitution
E32	Procedure:T63 Name:T64
T64	Procedure-Name 461 486	plasma volume restitution
T65	Observation 449 456	albumin
E33	Observation:T65 Name:T66
T66	Observation-Name 449 456	albumin
A17	Observation-Type-Value T66 lab
T67	Drug 411 441	balanced electrolyte solutions
E34	Drug:T67 Name:T68
T68	Drug-Name 411 441	balanced electrolyte solutions
T69	Or 442 448	and/or
E35	Or:T69 Arg:E34 Arg2:E33
R1	Using Arg1:E32 Arg2:E33	
R2	Using Arg1:E32 Arg2:E34	
T8	Allergy 513 520	Allergy
E8	Allergy:T8 Name:E36
T9	Drug 524 539	tranexamic acid
E36	Drug:T9 Name:T70
T70	Drug-Name 524 539	tranexamic acid
T71	Eq-Comparison 546 555	Receiving
E37	Eq-Comparison:T71 Temporal-Period:T72
T72	Eq-Temporal-Period 546 555	Receiving
A18	Eq-Temporal-Period-Value T72 present
T73	Drug 556 564	warfarin
E38	Drug:T73 Name:T74 Temporality:E37
T74	Drug-Name 556 564	warfarin
T75	Drug 568 575	heparin
E39	Drug:T75 Name:T76 Temporality:E37
T76	Drug-Name 568 575	heparin
T77	Or 565 567	or
E40	Or:T77 Arg:E38 Arg2:E39
T78	Condition 594 604	hemophilia
E41	Condition:T78 Name:T79 Temporality:E42
T79	Condition-Name 594 604	hemophilia
T80	Eq-Comparison 583 590	history
E42	Eq-Comparison:T80 Temporal-Period:T81
T81	Eq-Temporal-Period 583 590	history
A19	Eq-Temporal-Period-Value T81 past
T82	Condition 630 648	pulmonary embolism
E43	Condition:T82 Name:T83
T83	Condition-Name 630 648	pulmonary embolism
T84	Or 650 652	or
E44	Or:T84 Arg:E43 Arg2:E16
T85	Eq-Comparison 674 678	were
E45	Eq-Comparison:T85 Temporal-Period:T86
T86	Eq-Temporal-Period 674 678	were
A20	Eq-Temporal-Period-Value T86 past
T87	Condition 679 687	pregnant
E46	Condition:T87 Name:T88 Temporality:E45
T88	Condition-Name 679 687	pregnant
T89	Or 671 673	or
E47	Or:T89 Arg:E16 Arg2:E46
T90	Condition 712 735	cardiovascular problems
E48	Condition:T90 Name:T91
T91	Condition-Name 712 735	cardiovascular problems
T92	Condition 745 766	myocardiac infarction
E49	Condition:T92 Name:T93 Temporality:E50
T93	Condition-Name 745 766	myocardiac infarction
T94	Eq-Comparison 767 774	history
E50	Eq-Comparison:T94 Temporal-Period:T95
T95	Eq-Temporal-Period 767 774	history
A21	Eq-Temporal-Period-Value T95 past
R3	Example-Of Arg1:E49 Arg2:E48	
R4	Example-Of Arg1:E14 Arg2:E48	
T96	Condition 797 803	angina
E51	Condition:T96 Name:T97
T97	Condition-Name 797 803	angina
R5	Example-Of Arg1:E51 Arg2:E48	
T98	Condition 825 849	thromboembolic disorders
E52	Condition:T98 Name:T99
T99	Condition-Name 825 849	thromboembolic disorders
T100	Condition 887 904	general condition
E53	Condition:T100 Name:T101 Polarity:T102
T101	Condition-Name 887 904	general condition
T102	Polarity 873 886	deteriorating
A22	Polarity-Value T102 low
T103	Or 851 853	or
E54	Or:T103 Arg:E52 Arg2:E53
T104	Procedure 914 923	operative
E55	Procedure:T104 Name:T105
T105	Procedure-Name 914 923	operative
T106	Temporal-Connection 911 914	Pre
E56	Temporal-Connection:T106 Arg:E23 Arg2:E55
A23	Temporal-Connection-Type-Value E56 before
T107	Observation 934 944	hemoglobin
E57	Observation:T107 Name:T108 Eq-Comparison:E24
T108	Observation-Name 934 944	hemoglobin
A24	Observation-Type-Value T108 lab
T109	Eq-Unit 958 959	g
T110	Eq-Unit 960 962	dL
R6	Equivalent-To Arg1:E57 Arg2:E23	
R7	If-Then Arg1:T22 Arg2:E24	
T111	Eq-Unit 982 983	g
T112	Eq-Unit 984 986	dL
T113	Or 974 977	and
E58	Or:T113 Arg:T22 Arg2:T114
T114	Life-Stage-And-Gender 990 995	males
A25	Life-Stage-And-Gender-Type T114 male
R8	If-Then Arg1:T114 Arg2:E25	
T115	Procedure 1009 1023	blood products
E59	Procedure:T115 Name:T116
T116	Procedure-Name 1009 1023	blood products
T117	Assertion 998 1005	refusal
E60	Assertion:T117 Asserted:E59
A26	Assertion-Type-Value E60 hypothetical
T118	Procedure 1033 1042	operative
E61	Procedure:T118 Name:T119
T119	Procedure-Name 1033 1042	operative
T120	Temporal-Connection 1030 1033	Pre
E62	Temporal-Connection:T120 Arg:E12 Arg2:E61
A27	Temporal-Connection-Type-Value E62 before
T121	Eq-Comparison 1072 1088	within five days
E63	Eq-Comparison:T121 Operator:T28 Value:T122 Temporal-Unit:T32
T122	Eq-Value 1079 1083	five
T123	Procedure 1096 1103	surgery
E64	Procedure:T123 Name:T124
T124	Procedure-Name 1096 1103	surgery
T125	Temporal-Connection 1089 1095	before
E65	Temporal-Connection:T125 Arg:E63 Arg2:E64
A28	Temporal-Connection-Type-Value E65 before
T126	Procedure 1153 1179	antifibrinolytic treatment
E66	Procedure:T126 Name:T127
T127	Procedure-Name 1153 1179	antifibrinolytic treatment
R9	Treatment-For Arg1:E66 Arg2:E18	
T128	Assertion 1128 1137	requiring
E67	Assertion:T128 Asserted:E66
A29	Assertion-Type-Value E67 hypothetical
T129	Observation 1227 1241	platelet count
E68	Observation:T129 Name:T130 Eq-Comparison:E26
T130	Observation-Name 1227 1241	platelet count
A30	Observation-Type-Value T130 lab
T131	Procedure 1217 1226	operative
E69	Procedure:T131 Name:T132
T132	Procedure-Name 1217 1226	operative
T133	Temporal-Connection 1214 1217	pre
E70	Temporal-Connection:T133 Arg:E68 Arg2:E69
A31	Temporal-Connection-Type-Value E70 before
R10	Equivalent-To Arg1:E68 Arg2:E20	
T134	Eq-Operator 1245 1246	<
A32	Eq-Operator-Value T134 LT
T135	Observation 1262 1292	international normalized ratio
E71	Observation:T135 Name:T136 Eq-Comparison:E28
T136	Observation-Name 1262 1292	international normalized ratio
A33	Observation-Type-Value T136 lab
R11	Equivalent-To Arg1:E71 Arg2:E20	
T137	Observation 1317 1344	partial thromboplastin time
E72	Observation:T137 Name:T139 Polarity:T138 Eq-Comparison:E73
T138	Polarity 1307 1316	prolonged
A34	Polarity-Value T138 abnormal
T139	Observation-Name 1317 1344	partial thromboplastin time
A35	Observation-Type-Value T139 lab
T140	Eq-Comparison 1346 1363	>1.4 times normal
E73	Eq-Comparison:T140 Operator:T141 Value:T142 Unit:T143
T141	Eq-Operator 1346 1347	>
A36	Eq-Operator-Value T141 GT
T142	Eq-Value 1347 1350	1.4
T143	Eq-Unit 1357 1363	normal
A37	Eq-Unit-Value T143 ref-range-normal
R12	Equivalent-To Arg1:E72 Arg2:E20	
